Evaluation of neointimal coverage of overlapping sirolimus-eluting stents by optical coherence tomography

Chinese Medical Journal

Volumn 122, Issue 6, 2009, Pages 670-674

  Tian, Feng ^a,b   Chen, Yun Dai ^b   Sun, Zhi Jun ^b   Chen, Lian ^b   Yuan, Fei ^a   Song, Xian Tao ^a   Lü, Shu Zheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Chinese General Hospital   (China)

Author keywords

Coronary artery disease; Optical coherence tomography; Overlapping; Sirolimus eluting stent

Indexed keywords

RAPAMYCIN;

AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; HUMAN; IMAGE ANALYSIS; IMPLANTATION; OPTICAL COHERENCE TOMOGRAPHY; STENT THROMBOSIS; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 67649794838     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.06.015     Document Type: Article

References (21)

1. Kereiakes DJ, Wang H, Popma JJ, Kuntz RE, Donohoe DJ, Schofer J, et al. Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. J Am Coll Cardiol 2006; 48: 21-31.
2. Burzotta F, Siviglia M, Altamura L, Trani C, Leone AM, Romagnoli E, et al. Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. Am J Cardiol 2007; 99: 364-368.
3. Kang WC, Oh KJ, Han SH, Ahn TH, Chung WJ, Shin MS, et al. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents. Int J Cardiol 2007; 123: 12-17.
4. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005; 112: 270-278.
5. Lim SY, Jeong MH, Hong SJ, Lim do S, Moon JY, Hong YJ, et al. Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis. Circ J 2008; 72: 463-468.
6. Muñoz JS, Abizaid A, Mintz GS, Albertal M, Abizaid AS, Feres F, et al. Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents. Am J Cardiol 2004; 93: 470-473.
7. Kawaguchi R, Sabate M, Angiolillo DJ, Jimenez-Quevedo P, Suzuki N, Corros C, et al. Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus. Int J Cardiovasc Imaging 2008; 24: 125-132.
8. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Neishi Y, et al. Assessment of coronary intima media thickness by optical coherence tomography: comparison with intravascular ultrasound. Circ J 2005; 69: 903-907.
9. Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 2007; 99: 1033-1038.
10. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 2007; 28: 961-967.
11. Kotani J, Awata M, Nanto S, Uematsu M, Uematsu M, Oshima F, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006; 47: 2108-2111.
12. Takano M, Ohba T, Inami S, Seimiya K, Sakai S, Mizuno K. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation. Eur Heart J 2006; 27: 2189-2195.
13. Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 2005; 45: 1570-1573.
14. Degertekin M, Arampatzis CA, Lemos PA, Saia F, Hoye A, Daemen J, et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol 2004; 93: 826-829.
15. Shah VM, Mintz GS, Apple S, Weissman NJ. Background incidence of late malapposition after bare-metal stent implantation. Circulation 2002; 106: 1753-1755.
16. Mintz GS, Shah VM, Weissman NJ. Regional remodeling as the cause of late stent malapposition. Circulation 2003; 107: 2660-2663.
17. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 2004; 109: 881-886.
18. Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 2005; 46: 1002-1005.
19. Balakrishnan B, Tzafriri AR, Seifert P, Groothuis A, Rogers C, Edelman ER. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation 2005; 111: 2958-2965.
20. Suh SY, Rha SW, Na JO, Choi CU, Kim JW, Kim EJ, et al. The efficacy of adjunctive balloon postdilation at the overlapping site of drug-eluting stent in diffuse long coronary lesion. Coron Artery Dis 2008; 19: 211-215.
21. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al. Clopidogrel use and long-term clinical outcomes after DES implantation. JAMA 2007; 297: 159-168.